Research Centers of America’s Women’s Health Division has been conducting clinical trials for over 20 years and prides itself on the ability to execute early and late phase trials.
Our expertise lies in evaluating the safety and efficacy of investigational new drugs, products, and procedures for the treatment of gynecological disorders affecting the health and quality of life of women throughout various stages of life.
RCA is affiliated with a busy practice that has over 100 patient encounters per day. They also house the latest diagnostic equipment including transvaginal ultrasound, colposcopy, saline-infused sonohysterography, bone densitometry and punch and endometrial biopsies.
RCA is recognized in the pharmaceutical industry as a leader in providing expeditious and precise-scientific evaluation of therapeutic drugs in development. The Women’s Health Division also prides itself on its ability to execute early and late phase studies as well as OTC and non-pharmaceutical studies in the female population.
Some of the trials we have conducted are:
- Phase 1- Oral Contraceptives, Postmenopausal, Drug-Drug Interaction, and Device Trials
- Evaluation of diagnostics to be incorporated into the annual exam
- Human Papillomavirus (HPV) infections
- Hot Flashes
- Uterine Fibroids
- Hormone Replacement Therapy